Exchange Traded Concepts, LLC Biotechnology

Exchange Traded Concepts, LLC

$5.43 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TYRA Tyra Biosciences, Inc.	$409M	$110,000 0.0% of portfolio	11,861	Q1 2025 Added 42.71%
RCUS Arcus Biosciences, Inc.	$724M	$109,000 0.0% of portfolio	13,922	Q1 2025 Added 40.5%
IDYA Ideaya Biosciences, Inc.	$1.02B	$109,000 0.0% of portfolio	6,659	Q1 2025 Added 46.45%
JANX Janux Therapeutics, Inc.	$1.04B	$109,000 0.0% of portfolio	4,043	Q1 2025 Added 20.43%
AUTL Autolus Therapeutics PLC	$187M	$108,000 0.0% of portfolio	69,993	Q1 2025 Added 67.18%
BCYC Bicycle Therapeutics PLC	$254M	$108,000 0.0% of portfolio	12,764	Q1 2025 Added 90.31%
NRIX Nurix Therapeutics, Inc.	$572M	$108,000 0.0% of portfolio	9,145	Q1 2025 Added 38.92%
BMEA Biomea Fusion, Inc.	$68.8M	$107,000 0.0% of portfolio	50,550	Q1 2025 Added 140.89%
NUVB Nuvation Bio Inc.	$508M	$107,000 0.0% of portfolio	60,951	Q1 2025 Added 11.74%
ZNTL Zentalis Pharmaceuticals, Inc.	$77.5M	$107,000 0.0% of portfolio	67,401	Q1 2025 Added 48.11%
CGEM Cullinan Oncology, Inc.	$399M	$106,000 0.0% of portfolio	14,107	Q1 2025 Added 42.62%
PGEN Precigen, Inc.	$279M	$106,000 0.0% of portfolio	71,566	Q1 2025 Reduced 57.27%
VOR Vor Biopharma Inc.	$8.37M	$106,000 0.0% of portfolio	148,073	Q1 2025 Reduced 10.69%
REPL Replimune Group, Inc.	$472M	$105,000 0.0% of portfolio	10,814	Q1 2025 Reduced 32.45%
FATE Fate Therapeutics Inc	$132M	$104,000 0.0% of portfolio	131,830	Q1 2025 Added 211.74%
XNCR Xencor Inc	$546M	$104,000 0.0% of portfolio	9,814	Q1 2025 Added 23.95%
ITOS I Teos Therapeutics, Inc.	$356M	$103,000 0.0% of portfolio	17,308	Q1 2025 Added 25.06%
ARVN Arvinas, Inc.	$372M	$102,000 0.0% of portfolio	14,642	Q1 2025 Added 119.88%
CMPX Compass Therapeutics, Inc.	$222M	$102,000 0.0% of portfolio	54,207	Q1 2025 Reduced 44.65%
FHTX Foghorn Therapeutics Inc.	$174M	$101,000 0.0% of portfolio	27,693	Q1 2025 Added 53.13%
KYMR Kymera Therapeutics, Inc.	$2.36B	$101,000 0.0% of portfolio	3,693	Q1 2025 Added 6.92%
ALLO Allogene Therapeutics, Inc.	$194M	$100,000 0.0% of portfolio	68,858	Q1 2025 Added 13.49%
AURA Aura Biosciences, Inc.	$177M	$99,000 0.0% of portfolio	16,895	Q1 2025 Added 0.58%
RXRX Recursion Pharmaceuticals, Inc.	$792M	$98,000 0.0% of portfolio	18,624	Q1 2025 Reduced 63.31%
IONS Ionis Pharmaceuticals Inc	$4.93B	$97,000 0.0% of portfolio	3,244	Q1 2025 Added 1,722.47%
RLAY Relay Therapeutics, Inc.	$396M	$95,000 0.0% of portfolio	36,293	Q1 2025 Added 75.76%
TNGX Tango Therapeutics, Inc.	$225M	$89,000 0.0% of portfolio	65,327	Q1 2025 Added 274.88%
STRO Sutro Biopharma, Inc.	$49M	$88,000 0.0% of portfolio	136,623	Q1 2025 Added 201.86%
GLUE Monte Rosa Therapeutics, Inc.	$210M	$87,000 0.0% of portfolio	18,928	Q1 2025 Reduced 36.48%
MGNX Macrogenics Inc	$91.6M	$74,000 0.0% of portfolio	58,434	Q1 2025 Added 19.69%
KROS Keros Therapeutics, Inc.	$378M	$61,000 0.0% of portfolio	6,014	Q1 2025 Reduced 3.65%
CPRX Catalyst Pharmaceuticals, Inc.	$2.56B	$38,000 0.0% of portfolio	1,589	Q1 2025 Reduced 25.71%
ACAD Acadia Pharmaceuticals Inc	$3.56B	$29,000 0.0% of portfolio	1,776	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.